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bX-Ray Department, Craigavon Area Hospital, Portadown, Northern IrelandAbstractBackground: Sevoflurane anesthetic has recently been administered by anesthesiologists during voiding cystourethrograms in a centre where
radiologists are not permitted to deliver pediatric sedation.
Objective: To determine whether sevoflurane is a satisfactory anesthetic agent for voiding cystourethrography in children.
Methods: Records of children undergoing voiding cystourethrogram while they were under sevoflurane were reviewed for anesthetic adverse
effects and diagnostic quality of the cystourethrogram. The occurrence of on-table voiding and post-void residual bladder volume were
documented and compared with an age- and sex-matched control group of children undergoing unsedated voiding cystourethrography. The
caregivers were surveyed regarding the anesthetic experience.
Results: A total of 91 children underwent sevoflurane voiding cystourethrography; there were no adverse cardiorespiratory events. Voiding
was observed in 96%, with residual bladder volumes minimal in 38%, moderate in 32%, and large in 28% of anesthetized children, not
significantly different from the control group. Vesicoureteral reflux was observed in 53% of examinations under sevoflurane. When children
with a previous history of reflux or voiding cystourethrography were excluded in a comparison with age- and sex-matched controls, ves-
icoureteral reflux was observed in 38% of studies under sevoflurane and in 44% of studies in the control group, P ¼ .69; 85% of caregivers of
children with prior unsedated voiding cystourethrography found voiding cystourethrography with sevoflurane easier than without sevoflurane;
89% thought the anesthetic experience reduced their child’s anxiety towards medical procedures.
Conclusion: No adverse events or effects on diagnostic quality of the pediatric voiding cystourethrogram were encountered when using
sevoflurane. The majority of surveyed caregivers thought that anesthesia made voiding cystourethrography an easier experience for their
child.ResumeContexte: L’anesthesique sevoflurane a recemment ete administre par des anesthesistes au cours de cysto-uretrographies mictionnelles dans
un centre ou les radiologistes ne sont pas autorises a administrer la sedation en pediatrie.
Objectif: Determiner si le sevoflurane est un anesthesique satisfaisant pour la cysto-uretrographie mictionnelle chez l’enfant.
Methodes: Les dossiers des enfants ayant subi une cysto-uretrographie mictionnelle sous sevoflurane ont ete examines pour evaluer les effets
indesirables de l’anesthesie et la qualite diagnostique du cysto-uretrogramme. L’occurrence de la miction en cours d’examen et de residus
postmictionnels a ete documentee et comparee a un groupe temoin d’enfants apparies selon l’a^ge et le sexe ayant subi une cysto-ure-
trographie mictionnelle sans sedation. Un sondage sur l’experience de l’anesthesie a ete effectue aupres des parents et tuteurs.
Resultats: Au total, 91 enfants ont subi une cysto-uretrographie mictionnelle sous sevoflurane. Aucun evenement cardiorespiratoire
indesirable n’a ete observe. La miction a ete observee dans 96 % des cas, avec un residu postmictionnel minimal chez 38 %, moyen chez
32 % et important chez 28 % des enfants anesthesies, sans difference significative par rapport au groupe temoin. Un reflux vesico-ureteral
a ete observe dans 53 % des examens sous sevoflurane. Lorsque les enfants ayant des antecedents de reflux ou de cysto-uretrographie
mictionnelle etaient exclus d’une comparaison avec les sujets temoins apparies selon l’a^ge et le sexe, le reflux vesico-ureteral etait observe
dans 38 % des examens sous sevoflurane, contre 44 % dans le groupe temoin (P ¼ 0,69). Parmi les parents et tuteurs d’enfants ayant deja subi
une cysto-uretrographie mictionnelle sans sedation, 85 % ont trouve que l’examen sous sevoflurane s’est deroule plus facilement que celui
sans sevoflurane; 89 % ont juge que l’experience de l’anesthesie a reduit l’anxiete de leur enfant a l’egard des interventions medicales.* Address for correspondence: Michelle L. Noga, MD, Department of
Radiology and Diagnostic Imaging, University of Alberta, 2A2.41 Walter
Mackenzie Centre, 8440-112 St, Edmonton, Alberta T6G 2B7, Canada.
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223Sevoflurane in pediatric voiding cystourethrography / Canadian Association of Radiologists Journal 63 (2012) 222e227Conclusion: Aucun evenement indesirable ou des effets sur la qualite diagnostique du cysto-uretrogramme mictionnel pediatrique n’a ete
observe avec l’administration de sevoflurane. La majorite des parents et tuteurs sondes estiment que l’anesthesie a rendu l’experience de la
cysto-uretrographie mictionnelle plus facile pour leur enfant.
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Key Words: Pediatric cystography anesthesiaVoiding cystourethrography (VCUG) is a common fluo-
roscopic radiologic examination, which is used for detection
of urinary tract abnormalities. It is frequently performed in
children, with more than 530 examinations performed per
year in our institution. It is an invasive procedure, which
involves the insertion of a catheter into the urinary bladder
and retrograde instillation of contrast medium. The exami-
nation may be psychologically traumatic for parents and
patients alike [1,2]. Sedation of selected pediatric patients is
an accepted practice, and its use has been documented in the
peer-reviewed literature [3e7].
Pediatric sedation during VCUG, although used in current
practice, has not been extensively researched. In a random-
ized double-blinded study, Stokland et al [4] demonstrated
that the use of midazolam made the VCUG less distressing
for both parents and patients. Keidan et al [8] compared the
efficacy of oral midazolam and nitrous oxide, and found that
they were comparable in reducing anxiety and distress but
that nitrous oxide provided a more-rapid onset of sedation
and a shorter recovery time. In the study by Schmit and Sfez
[9], rectal midazolam reduced pain and stress during VCUG
in children of both sexes under age 5 years, but nitrous oxide
only did so in girls. The use of intranasal fentanyl recently
has been described to decrease pain on catheterization during
VCUG but demonstrated no decrease in pain compared with
placebo [10]. In many pediatric institutions, such as ours,
radiologists are not permitted to deliver conscious sedation,
based on local medical safety regulations. The task of
providing sedation for children undergoing VCUG is given
to the pediatric anesthesiologists, who prefer to use inhala-
tional anesthetic agents such as sevoflurane. The use of this
agent has been studied in pediatric magnetic resonance
imaging [11,12], but, to date, no evaluation of the use of
sevoflurane for the pediatric VCUG examination has been
reported.
Sevoflurane is an ether inhalation anesthetic agent, which
can be rapidly and conveniently administered without
discomfort. Its low solubility facilitates precise control over
the depth of anesthesia and a rapid and smooth induction of,
and emergence from, general anesthesia [13]. The charac-
teristics of rapid induction and emergence are ideal proper-
ties of an anesthetic agent for the purpose of a VCUG, with
deeper anesthesia only required for a short time during
bladder catheterization and rapid emergence that enables the
patient to have regained consciousness sufficiently to coop-
erate with voiding on the fluoroscopy table. Sevoflurane has
been extensively studied for induction and maintenance of
anesthesia in children younger than 18 years old (usuallyAmerican Society of Anesthesiologists class I and II)
undergoing ambulatory (day-case or outpatient) surgery and,
to a lesser extent, in nonambulatory surgery that lasts fewer
than 5 hours [13]. Reported adverse effects include cough,
laryngospasm, breath holding, agitation and/or excitement,
nausea, vomiting, and malignant hyperthermia [13,14].
The objective of this study was to determine whether
inhalational sevoflurane is a satisfactory anesthetic agent for
obtaining a diagnostic voiding cystourethrogram in pediatric
patients with respect to patient safety and acceptability, and
the effect on the diagnostic quality of the examination.
Patients and Methods
A retrospective cohort study was performed on children
undergoing anesthetized and unsedated VCUG at Stollery
Children’s Hospital between April 2004 and November
2008. The images and patient records of all patients under-
going VCUG under general anesthetic with sevoflurane as
the sole anesthetic agent were reviewed for adverse effects
from anesthetic, diagnostic quality of the VCUG, time from
anesthetic to recovery, and time from recovery to discharge.
A subset of 53 children who received sevoflurane for first-
time VCUG, with no history of vesicoureteral reflux
(VUR), were identified. Records of a corresponding age- and
sex-matched control group of 53 randomly selected children
undergoing VCUG without sedation from the same time
period as the subset of 53 children who received sevoflurane
were reviewed with respect to diagnostic quality of the
VCUG. The control group also had no history of VUR or
VCUG. If more than one child matched in age and sex to
a sevoflurane subject, then the child with the examination
closest to the time of the sevoflurane subject was selected.
Children were referred for VCUG with anesthesia by their
referring physician, mostly urologists, nephrologists, and
pediatricians. Sevoflurane was administered by inhalation just
before bladder catheterization, and administration terminated
at the initiation of bladder filling. The VCUG images and
reports were reviewed for diagnostic quality, particularly for
the occurrence of on-table voiding, residual urine volume
present within the bladder after micturition, presence and
grade of VUR. VUR was graded by the international classi-
fication of VUR, where I represents reflux into a nondilated
ureter; II represents reflux into the renal pelvis without dila-
tation; III represents mild dilatation of the ureter, renal pelvis,
and calyces; IV represents moderate dilatation of the renal
pelvis and calyces, with moderate ureteral tortuosity; and V
represents gross dilatation of the collecting system, ureteral
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was no reflux, VUR was graded as 0. If there was bilateral
VUR, then the higher grade was recorded. The final recorded
bladder image was taken as the postvoid image unless
otherwise stated in the formal report. Residual volume was
graded by dividing the pelvis into thirds (Figure 1) with grade
1 (no or small residual volume), grade 2 (moderate residual
volume, above the acetabulum), and grade 3 (large residual
volume, above the mid sacroiliac joint). Residual bladder
volume was only graded for patients who voided on the table.
Age, postvoid residual bladder volumes, and VUR grade were
compared between the sedated and unsedated groups by using
the Student unpaired t test. The incidence of on-table voiding
and VUR was compared between groups by using the Fisher
exact test.
Parents remained with their child from admission to
anesthetic induction, with most parents leaving during the
time the child was unconscious, at the discretion of the
anesthesiologist. Those parents who left after induction
returned when the child began to regain consciousness. AFigure 1. Residual bladder volume grading system. For grade I (minimal)
volumes, the bladder was below the level of the acetabula, denoted by the
lower line. Grade II (moderate) volumes were assigned when the bladder
dome was above the acetabula but below the mid sacroiliac joint level
(denoted by the upper line). Grade III (large) volumes were assigned when
the bladder dome reached above the midpoint of the sacroiliac joints,
denoted by the upper line. A right duplex collecting system with ves-
icoureteral reflux into both systems is present in this patient.follow-up questionnaire was sent to the child’s parents after
the procedure to assess their opinion of their child’s experi-
ence with VCUG under sedation, with the same question-
naire administered by telephone to nonresponders within
1 month of the procedure (Table 1). Confidence intervals for
responses were calculated by using the modified Wald
equation. The study was approved by the University of
Alberta Health Research Ethics Board.
Results
From April 2004 to November 2008, all pediatric patients
who underwent a VCUG with sevoflurane as the only anes-
thetic induction agent during bladder catheterization were
included in the study. Ninety-six patients met inclusion
criteria. Five patients were excluded for the following
reasons, VCUG and Dimercaptosuccinic acid (DMSA) scans
performed at the same visit (n ¼ 3), VCUG and eye exam-
ination at the same visit (n ¼ 1), and recovery room sheet not
available from the medical record (n ¼ 1). Therefore, data
were calculated on 91 examinations on 88 patients. Three
patients had a second VCUG under sevoflurane anesthesia,
with an intervening period of more than 1 year between
studies.
The median patient age was 47 months (range, 10-195
months). There was a female predominance of patients
(74%). Indications for VCUG included query VUR (n ¼ 54),
follow-up VUR (n ¼ 33), duplex collecting system (n ¼ 1),
bladder dysfunction (n ¼ 1), urethral stricture (n ¼ 1), mul-
ticystic dysplastic kidney (n ¼ 1), recurrent cystitis (n ¼ 1),
and renal transplant (n ¼ 1).
Agitation was reported in examinations of 3 children (3%)
by the recovery room staff. Other reported adverse effects
included sore throat (n ¼ 1) and coughing (n ¼ 1). None of
the known adverse effects of sevoflurane, such as lar-
yngospasm, nausea, vomiting, and malignant hyperthermia,
were reported by anesthesiologists or recovery room staff.
No child visited the emergency department after the proce-
dure for anesthetic or other complications. There were no
reports of cardiac or respiratory events during or after
anesthetic.
There were no radiologist reports of nondiagnostic VCUG
examinations in children anesthetized with sevoflurane.
Voiding occurred in 87 examinations (96%) in sedated
children (Table 2). VUR was identified in all 4 children who
did not void on the table. VUR was demonstrated in 48
children: 54% of girls and 46% of boys. The grade of reflux
ranged from no reflux to grade IV, with a mean (SD) grade of
1.26  1.51, median 0. Residual bladder volumes were
graded as 1 (38%), 2 (32%), and 3 (28%) for patients who
voided on the table, with a mean of 1.87, with 2 examina-
tions having no postvoid image obtained.
The age- and sex-matched control unsedated group
(Table 2) median age was 47 months, and 17% were boys,
exactly the same as the sevoflurane group, with no previous
VUR or VCUG (P > .9). Voiding occurred in 94% of
examinations in both groups (P > .9), and reflux was
Table 1
Patient caregiver survey questions and responses regarding children who received sevoflurane anesthesia for VCUG
Question Yes, n (%) No, n (%) Neutral
Has your child previously had a VCUG? 20 (50) 20 (50)
Has your child had a prior medical procedure that he or she did not tolerate well? 30 (75) 10 (25)
Were you present during the VCUG procedure? 11 (35) 20 (65)
Were you comfortable with how your child was coping during the VCUG? 9 (82) 2 (18)
In your opinion, was this VCUG less difficult for your child than the first time (if applicable)? 17 (85) 1 (5) 10 (2)
Did you believe the sedation made the VCUG an easier experience for your child? 29 (85) 0 (0) 15 (5)
Do you believe that having the VCUG under sedation has made your child less anxious about
medical procedures as a whole?
32 (76) 4 (10) 14 (6)
VCUG ¼ voiding cystourethrography.
225Sevoflurane in pediatric voiding cystourethrography / Canadian Association of Radiologists Journal 63 (2012) 222e227identified in none of the 3 control patients who did not void
on the table. VUR was observed in 42% of studies, not
significantly different than 36% in the corresponding sedated
group (P ¼ .69). The mean grade of VUR was 1.08 for the
control group and 0.81 for the sevoflurane group, with
a range of 0-4, not a significant difference (P ¼ .28).
Residual bladder volumes were graded as 1 (n ¼ 24 [48%]),
2 (n ¼ 18 [36%]), and 3 (n ¼ 8 [16%]), with a mean of 1.68,
not significantly different from the sedated group, with
a mean of 1.90 (P ¼ .16). Three control patients did not void
on the table.
Anesthetic to recovery time was available in 88 examina-
tions: mean, 18 9minutes; range, 5-40minutes; andmedian,
15 minutes. Time from recovery to discharge was available in
89 examinations: mean, 16 minutes; range, 4-55 minutes;
median, 15 minutes. Total time from anesthetic to discharge:
mean, 43 minutes; range, 10-85 minutes; median, 35 minutes.
A total of 42 patients’ families participated in a ques-
tionnaire, but not all questions were answered by all
respondents (Table 1). A large proportion of children, 50%,
had prior VCUG (95% confidence interval [CI], 35%-65%)
or prior medical procedure, 75% (95% CI, 60%-86%). A
minority of caregivers (35%) were present during the VCUG,
with most of these (81%) reporting that they were comfort-
able with their child’s coping during the procedure (95% CI,
51%-96%). The majority of parents (85%) thought that
VCUG under sevoflurane was easier than before (unsedated)
(95% CI, 63%-96%), and the same proportion of parents
thought that sedation made the VCUG easier for the childTable 2
Comparison of children who received sevoflurane for VCUG with children who
controls who received no sedation for first-time VCUG
Sevoflurane
VCUG, N ¼ 91
Age, mean (SD), median, mo 53  37.3, 47
Boys, n (%) 24 (26)
Voided on table, n (%) 87 (96)
Residual volume, n (%)
Grade 1 33 (38)
Grade 2 28 (32)
Grade 3 24 (28)
No postvoid image 2 (2)
Mean (SD) residual volume grade 1.87  0.81
Presence of reflux, n (%) 48 (53)
Reflux, mean (SD), median 1.26  1.51, 0
SD ¼ standard deviation; VCUG ¼ voiding cystourethrography.(95% CI, 69%-94%). Most caregivers (76%) thought the
child’s experience of a VCUG under sevoflurane would make
their child less anxious about future medical procedures
(95% CI, 61%-87%).
Discussion
Sevoflurane was evaluated for patient safety and accept-
ability, and for the effect on the diagnostic quality of the
VCUG. With regard to safety, there were no cardiorespira-
tory complications from sevoflurane anesthesia for VCUG,
with no incidents reported in 91 events. This rate is
comparable with the 0.4% rate reported by Sanborn et al [16]
in a much larger series that evaluated sevoflurane adverse
effects. Minor adverse effects, such as agitation, sore throat,
and coughing were observed in a minority of patients after
the anesthetic. Agitation or emergence delirium, which has
been described with use of sevoflurane for imaging tests
[11,17], was seen in 3% of patients in our study, which is
lower than the 9% rate reported by Bryan [11] for sevo-
flurane during magnetic resonance imaging. A meta-analysis
of sevoflurane emergence agitation for all procedures
reported an incidence of 26% [18]. Our lower incidence of
agitation is likely related to a lower overall dose of sevo-
flurane, given the relatively short duration of the test. The
observation of sore throat has not been reported with sevo-
flurane anesthesia and may be related to preexisting illness,
because there was no airway intervention or placement of
nasoenteric tubes during the anesthesia.received sevoflurane for first-time VCUG and with age- and sex-matched
Sevoflurane first-time
VCUG, N ¼ 53
Unsedated first-time
VCUG, N ¼ 53
55  35.3, 47 55  36.1, 47
9 (18) 9 (18)
50 (94) 50 (94)
20 (40) 24 (48)
17 (34) 18 (36)
14 (28) 8 (16)
0 (0) 0 (0)
1.88  0.81 1.68  0.73
19 (36) 22 (42)
0.81  1.18, 0 1.08  1.31, 0
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nondiagnostic, voiding was not achieved on the table in 4
patients. The radiologists’ confidence in the examinations
may be related to the observation of VUR in all of the chil-
dren who did not void on the table. The proportion of children
who did not void on the table was not significantly different
from the control group in our study. The nonvoiding rate was
similar to that reported by Stokland [4] for children who
received midazolam (2 of 48 children did not void) and for
children who received placebo (9 of 47 children did not void).
Other studies concluded that oral midazolam does not alter
the rate of micturition or postvoid residual urine volume, but
these studies do not state the number of children who ach-
ieved on-table voiding [3,5]. Bozkurt [19] showed that
intranasal midazolam had no effect on urodynamic variables
in children. Studies that report the use of nitrous oxide did not
report the occurrence of voiding or reflux [8,9].
Sevoflurane did not have a significant effect on voiding in
this study. The volume of residual urine after micturition is of
concern, because 52% of patients had at least a moderate
postvoid residual volume of urine. However, the proportion of
unsedated children with moderate-to-large residual bladder
volumes also was high, with no significant difference in the
average residual bladder volume grading, therefore, it is
difficult to attribute larger residual bladder volumes to sevo-
flurane. Residual urine could potentially limit the ability of
a VCUG to detect low-grade reflux. It is unknown whether the
absence of voiding or larger postvoid residual urine volumes
had any effect on the observation of reflux; the 50% rate of
reflux was higher than in the other studies, 31% and 16 %
[4,5]. The higher rate of reflux was in keeping with a high
proportion of children who had previous VCUG, 50% of
surveyed children, and 42% of all children who received
sevoflurane. When children who received sevoflurane and
with a history of VUR or previous VCUG were excluded, and
the remaining group compared with age- and sex-matched
unsedated controls, the incidence of reflux in both groups
was lower, with the 36% incidence in the sevoflurane group
comparable with other reported rates [4,5] and not signifi-
cantly different from the control group (42%). Therefore, it is
unlikely that use of sevoflurane resulted in the observation of
higher rates of VUR than in unsedated children.
The age of children who received sevoflurane for VCUG
was older than the usual unsedated group at our institution,
where the mean age was 29 months and the median age of 13
months. The older age of the patientswho received sevoflurane
likely reflects the referral pattern for sedation, with anesthesia
being performed at the request of physicians and their patients,
because most physicians would not expect infants to have
a recollection of the procedure. The female predominance
among the sedated group reflects the bias towards patientswith
VUR as urinary tract infection associated radiologic abnor-
malities are more common in females [20e22].
The patients were not catheterized to quantitate the
residual volumes of urine, which is a limitation of the
grading system of residual volume. Recatheterization was
not thought to be clinically acceptable because children werealready awake at the time of voiding. Also, the volume of
residual urine was estimated based on the last image of the
bladder. Although this assumption could result in over-
estimation of the residual urine volumes, it is the standard
practice at our institution for radiologists to obtain a final
fluoroscopic image of the bladder after voiding.
Sevoflurane anesthetic did not add significant time to the
duration of the VCUG, in keeping with its rapid induction and
emergence times. A mean time of 18 minutes from start of
anesthesia to recovery room was observed. In a busy pediatric
radiology practice, there was concern that sedation could
decreaseproductivity; however, theprocedural time for a sedated
VCUG is comparable with that for an unsedated VCUG; based
on 15 consecutive unsedated patients in our practice, the median
timewas 15minutes, withmost examinations in the range of 14-
16 minutes. There are no reports in the medical literature of the
average procedural time of a VCUG. It was not possible to
measure the examination time for the control group because
initial starting timeswere not documented in themedical record.
The patients were referred for VCUG with anesthetic by
a pediatric nephrologist, pediatric urologist, or pediatrician. The
majority of childrenwho had anesthesia had a previous medical
procedure, including 50% of the children of survey respondents
with a previous VCUG without sedation (42% of all patients
who received sevoflurane). It would appear that a previous
unpleasant experience with medical procedures affected the
decision to request anesthesia and could have biased the
proportion of caregivers who chose to respond to the survey and
their responses. However, it is not standard clinical practice to
sedate all children for VCUG; children with previous traumatic
experience with medical procedures or those likely to be trau-
matized by VCUG are the group most likely to benefit from
anesthesia. This group of patients was represented in the survey.
Based on the survey, the majority of respondents had a positive
response to the use of sevoflurane, with most indicating that the
procedure seemed easier for the child with sevoflurane and
easier than previous unsedated VCUG experiences. The
majority of respondents also thought that the anesthetic expe-
rience lessened their child’s anxiety about future medical
procedures; there has been concern raised about VCUGwithout
sedation resulting in fear of future medical procedures [1].
One limitation of the survey was that it was sent only to
the group that received sevoflurane anesthesia and the
questions were directed towards the sedation VCUG expe-
rience generally rather than to sevoflurane in particular.
Therefore, these generally positive responses, although
obtained in the context of sevoflurane anesthesia for VCUG,
were without comparison to another agent or placebo, and
may have reflected a general preference for sedation.
However, sevoflurane anesthesia for VCUG did not result in
a significant proportion of negative responses. Also, only
35% of the survey respondents were in the room for the
entire VCUG, so positive response may have been related to
parents’ absence from a portion of the VCUG. Of the survey
respondents who witnessed the entire VCUG, 81% had
a positive impression. The caregivers of patients who
received no sedation were not surveyed, and their rate of
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the patients’ caregivers did not participate in the survey,
therefore, the survey numbers are relatively small, and the
results are difficult to generalize.
A limitation of this study was its retrospective nature.
Postanesthetic responses, such as agitation, were not quanti-
fied. There was no placebo, because it was not ethical to use
a placebo when patients were expecting an anesthetic. A
comparison agent, such as propofol, was not used because
clinical experience by the anesthesiologists and radiologists
involved quickly showed sevoflurane to be the preferable agent,
based on very long emergence times with propofol. There was
no comparison with conscious sedation, such as midazolam,
nitrous oxide, or fentanyl, because, at our institution, radiolo-
gists are not permitted to administer this agent, and anesthesi-
ologists do not use these agents for this purpose. Therefore,
a comparison group could not ethically be used. It remains
necessary to evaluate anesthetic agents, such as sevoflurane,
commonly used by anesthesiologists for radiologic procedures.
An ideal anesthetic agent should have no adverse effects,
should be acceptable to patients, have rapid induction and
emergence times, and should have no smooth-muscle
relaxation qualities so that voiding and the occurrence of
VUR are not affected. Midazolam and nitrous oxide have
demonstrated these properties. Sevoflurane, theoretically, is
less ideal because it has smooth-muscle relaxation properties
[13], but there was no effect on voiding or the prevalence of
VUR in this study. Sevoflurane satisfied the other criteria for
an ideal anesthetic agent for VCUG in this study.
Conclusion
Sevoflurane was a satisfactory anesthetic agent for pedi-
atric VCUG in this study, based on safety, acceptability to
patients, and no obvious influence on the diagnostic quality
of VCUG. It was safe, with no cardiorespiratory events and
minimal adverse effects in our limited experience. Patients’
caregivers demonstrated generally positive responses when
surveyed about the anesthetic experience with sevoflurane,
which suggests that the agent generally was acceptable to
patients This anesthetic agent was acceptable to the radiol-
ogist, without significant effect on the diagnostic quality of
the voiding cystourethrogram and without adding signifi-
cantly to the time required to perform the examination.References
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